The Role of Chemoprevention of Colorectal Cancer with 5-Aminosalicylates in Ulcerative Colitis

被引：13
|
作者：
Herfarth, Hans [1 ]
机构：
[1] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC 27599 USA
来源：
DIGESTIVE DISEASES | 2012年 / 30卷
关键词：
Anti-inflammatory agents; Non-steroidal/therapeutic use; Mesalamine; Colorectal cancer; Ulcerative colitis; Crohn's disease; Inflammatory bowel disease; INFLAMMATORY-BOWEL-DISEASE; RISK-FACTORS; RANDOMIZED-TRIAL; NEOPLASIA; MESALAZINE; DYSPLASIA; THERAPY; PREVENT; ACID; ADENOMAS;
D O I：
10.1159/000341894
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
5-aminosalicylates (5-ASA) are widely used to treat patients with ulcerative colitis. Experimental data suggest that these agents can potentially be used in a chemopreventive fashion to inhibit the development of colitis-associated colorectal cancer (CRC); however, observational studies investigating a possible risk reduction of CRC by 5-ASA therapy have revealed conflicting results. Currently, it appears that 5-ASA have no or only a very limited effect as a deterrence against CRC. Thus, a general recommendation for long-term use of 5-ASA solely for chemopreventive measures is not warranted. Copyright (c) 2012 S. Karger AG, Basel
引用
收藏
页码：55 / 59
页数：5
相关论文
共 50 条
  • [41] Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practice
    Ben-Horin, Shomron
    Andrews, Jane M.
    Katsanos, Konstantinos H.
    Rieder, Florian
    Steinwurz, Flavio
    Karmiris, Konstantinos
    Cheon, Jae Hee
    Moran, Gordon William
    Cesarini, Monica
    Stone, Christian D.
    Schwartz, Doron
    Protic, Marijana
    Roblin, Xavier
    Roda, Giulia
    Chen, Min-Hu
    Har-Noy, Ofir
    Bernstein, Charles N.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (16) : 2995 - 3002
  • [42] Clinical outcomes for ulcerative colitis patients stopping 5-aminosalicylates starting biologics and/or immunomodulator therapy: A Systematic review and meta-analysis
    Moon, J. R.
    Na, J. E.
    Ji, J. H.
    Lee, H. S.
    Park, J. J.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1890 - I1890
  • [43] No Benefit of Concomitant 5-Aminosalicylates in Patients With Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data From Clinical Trials
    Singh, Siddharth
    Proudfoot, James A.
    Dulai, Parambir S.
    Jairath, Vipul
    Fumery, Mathurin
    Xu, Ronghui
    Feagan, Brian G.
    Sandborn, William J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 (08): : 1197 - 1205
  • [44] Efficacy of Oral vs. Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Meta-Analysis
    Ford, Alexander C.
    Khan, Khurram J.
    Achkar, Jean-Paul
    Moayyedi, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (02): : 167 - 176
  • [45] Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practice
    Shomron Ben-Horin
    Jane M Andrews
    Konstantinos H Katsanos
    Florian Rieder
    Flavio Steinwurz
    Konstantinos Karmiris
    Jae Hee Cheon
    Gordon William Moran
    Monica Cesarini
    Christian D Stone
    Doron Schwartz
    Marijana Protic
    Xavier Roblin
    Giulia Roda
    Min-Hu Chen
    Ofir Har-Noy
    Charles N Bernstein
    World Journal of Gastroenterology, 2017, (16) : 2995 - 3002
  • [46] Biology of cancer in ulcerative colitis and consequences for chemoprevention
    Boland, CR
    Gasché, C
    Marra, G
    Chang, CL
    Inflammatory Bowel Disease: Translation From Basic Research to Clinical Practice, 2005, 140 : 259 - 269
  • [47] Aminosalicylates in Ulcerative Colitis: old but gold?
    Sequeira, C.
    Santos, I.
    Coelho, M.
    Teixeira, C.
    Mangualde, J.
    Cremers, I.
    Oliveira, A.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I433 - I433
  • [48] Aminosalicylates in Ulcerative Colitis: old but gold?
    Sequeira, C.
    Santos, I.
    Coelho, M.
    Teixeira, C.
    Mangualde, J.
    Cremers, I.
    Oliveira, A.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I433 - I433
  • [49] Tofacitinib efficacy in patients with moderate to severe ulcerative colitis: Subgroup analyses of OCTAVE Induction 1 and 2 and OCTAVE Sustain by 5-aminosalicylates use
    Hanauer, S.
    Rubin, D. T.
    Gionchetti, P.
    Su, C.
    Woodworth, D. A.
    Quirk, D.
    Salese, L.
    Wang, W.
    Marren, A.
    Lawendy, N.
    Panaccione, R.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S477 - S477
  • [50] Efficacy and safety of oral beclomethasone dipropionate and budesonide MMX versus 5-aminosalicylates or placebo in ulcerative colitis: a systematic review and meta-analysis
    Barberio, Brigida
    Marsilio, Ilaria
    Buda, Andrea
    Bertin, Luisa
    Semprucci, Gianluca
    Zanini, Annalisa
    Crepaldi, Martina
    Zingone, Fabiana
    Savarino, Edoardo
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
12345